Table 2.
Comparison of general information between Group A and Group B ± s, M (Q)
| Variable | Group A | Group B | t (U) value | P value | |
|---|---|---|---|---|---|
| N | 49 | 46 | |||
| BMI (kg/m2) | At baseline | 24.04 ± 3.12 | 23.66 ± 3.76 | 0.538 | 0.592 |
| After 12 weeks | 24.23 ± 3.01 | 23.76 ± 3.70 | 0.671 | 0.504 | |
| TC (mmol/l) | At baseline | 4.52 ± 1.28 | 4.40 ± 1.02 | 0.483 | 0.630 |
| After 12 weeks | 3.80 ± 0.89 | 3.85 ± 0.84 | − 0.299 | 0.765 | |
| TG (mmol/l) | At baseline | 1.37 ± 0.70 | 1.29 ± 0.54 | 0.598 | 0.551 |
| After 12 weeks | 1.58 ± 1.03 | 1.30 ± 0.71 | 1.508 | 0.135 | |
| Lp (a) (mmol/l)a | At baseline | 16.90 (36.40) | 13.40 (51.56) | 976.000 | 0.780 |
| After 12 weeks | 15.50 (21.90) | 13.94 (32.05) | 1057 | 0.854 | |
| ApoA (g/l) | At baseline | 1.31 ± 0.33 | 1.35 ± 0.26 | − 0.711 | 0.479 |
| After 12 weeks | 1.37 ± 0.29 | 1.41 ± 0.28 | − 0.758 | 0.451 | |
| ApoB (g/l) | At baseline | 0.85 ± 0.23 | 0.86 ± 0.25 | − 0.031 | 0.976 |
| After 12 weeks | 0.70 ± 0.20 | 0.70 ± 0.21 | − 0.030 | 0.976 | |
| HDL-C (mmol/l) | At baseline | 1.13 ± 0.29 | 1.17 ± 0.23 | − 0.672 | 0.503 |
| After 12 weeks | 1.20 ± 0.29 | 1.27 ± 0.33 | − 1.11 | 0.270 | |
| LDL-C (mmol/l) | At baseline | 2.83 ± 1.09 | 2.75 ± 0.88 | 0.376 | 0.708 |
| After 12 weeks | 2.22 ± 0.69 | 2.08 ± 0.64 | 1.063 | 0.291 | |
| LP-PLA2 (umol/l) | At baseline | 249.58 ± 129.24 | 221.37 ± 148.8 | 0.976 | 0.332 |
| After 12 weeks | 219.13 ± 117.70 | 155.87 ± 93.80* | 2.875 | 0.005 |
aMedian and quartile. M (Q) median (quartile), BMI body mass index, TC total cholesterol, TG three acyl glycerin, ApoA apolipoprotein A, ApoB apolipoprotein B, Lp (a) lipoprotein (a), LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, LP-PLA2 Lipoprotein-associated Phospholipase A2. Compared between Group A and Group B
*P < 0.05